Unilife Corp (NASDAQ:UNIS) up by 32.97%, Sequenom Inc. (NASDAQ:SQNM)

Posted by Lynn Eisler May 10, 2013 0 Comment 1422 views


Hartford, CT 05/10/2013 (GDPInsider) – Unilife Corp (NASDAQ:UNIS) is up by about 32.97% after hitting a high of $2.50 during the day, and is now hovering at $2.45. The traded volumes during the day was lower than the average volume of 0.708 million, and the current trading volume is more than 2.78 million. The beta of the stock is 1.20. With a book value per share of about 0.48 the price to book value ratio of the Unilife is close to 3.85 which is quite decent. The investors can get a clue about the stock’s performance from the investors holding in the company’s share which is close to 4.76% as of May 10, at the same time the institutional investors are holding about 34.32% in the company’s stock. The net profit margin over the trailing twelve months of the company is close to -1470.63%. The analysts’ are expecting a price of $6.35 for the stock, thus we can expect the stock to rise further expect.

The company yesterday reported its 1Q2013 loss per share of $0.17 as compared to a loss of $0.21 per share. Revenues were $0.7 million versus revenue of $1.3 million in 1Q2012.

Is UNIS a solid investment at these levels? Get valuable updates and exclusive insights here.

Sequenom, Inc. (NASDAQ:SQNM) is down by about 17.09% after hitting a high of $4.22 during the day, and is now hovering at $4.18. The traded volumes during the day were higher than the average volume of 2.34 million, and the current trading volume is more than 5.55 million. The beta of the stock is 0.06. With a book value per share of about 0.41 the price to book value ratio of the Sequenom is close to 8.71 which is quite decent. The investors can get a clue about the stock’s performance from the investors holding in the company’s share which is close to 0.07% as of May 10, at the same time the institutional investors are holding about 72.41% in the company’s stock. The net profit margin over the trailing twelve months of the company is close to -130.47%. The analysts’ are expecting a price of $6.56 for the stock, thus we can expect the stock to rise further expect.

The company reported its 1Q2013 results where it reported a net loss of $11.3 million or $0.22 diluted per share as compared to a net loss of $13.1 million or $0.39 diluted per share in 1Q2012. Revenues is close to $38.5 million which increased by whopping 158% from the previous year’s revenue of $14.9 million.

How Should Investors Trade SQNM Now? Get the latest trends and data here.

Disclosure:

WallStreetAnalyzed.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetAnalyzed.com website, for complete risks and disclosures.


About Lynn Eisler

Lynn Eisler is a national news reporter focusing on economic issues, data analysis and the financial health of state and local governments. Lynn has been honored with the H.L. Mencken Award for Investigative Reporting, the Champion of Justice Award for reporting on the drug war, and the John Hancock Award for business reporting. Lynn was also a Knight Medical School Fellow at the University of Michigan.

View all post by Lynn Eisler Visit author's website

Write Your Comment